Clinical Trial Update: A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ampicillin/sulbactam to moxifloxacin for complicated intra-abdominal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection

Drugs mentioned

• Avelox (moxifloxacin) (moxifloxacin)
• Unasyn (ampicillin/sulbactam) (ampicillin/sulbactam)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Intra-abdominal Infection | Phase 4 | Status: COMPLETED